Palforzia is a medicine for treating peanut allergy in children from 1 to 17 years of age and patients who become adults whilst on treatment. While taking this medicine, patients continue avoiding peanuts. Palforzia contains peanut powder.
Therapeutic Indication
### Therapeutic indication Palforzia is indicated for the treatment of patients aged 1 to 17 years with a confirmed diagnosis of peanut allergy. Palforzia may be continued in patients 18 years of age and older. Palforzia should be used in conjunction with a peanut-avoidant diet.
Therapeutic Area (MeSH)
ATC Code
V01
ATC Item
过敏原
Pharmacotherapeutic Group
Allergens
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| defatted powder of Arachis hypogaea L., semen (peanuts) | N/A | defatted powder of arachis hypogaea l., semen (peanuts) |
EMA Name
Palforzia
Medicine Name
Palforzia
Aliases
N/A
